Yumanity Therapeutics (FRA:8IY) Total Liabilities : €4.14 Mil (As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Total Liabilities?

Yumanity Therapeutics's Total Liabilities for the quarter that ended in Sep. 2022 was €4.14 Mil.

Yumanity Therapeutics's quarterly Total Liabilities declined from Mar. 2022 (€18.03 Mil) to Jun. 2022 (€7.13 Mil) and declined from Jun. 2022 (€7.13 Mil) to Sep. 2022 (€4.14 Mil).

Yumanity Therapeutics's annual Total Liabilities declined from Dec. 2019 (€98.56 Mil) to Dec. 2020 (€48.19 Mil) and declined from Dec. 2020 (€48.19 Mil) to Dec. 2021 (€34.90 Mil).

Yumanity Therapeutics Total Liabilities Historical Data

The historical data trend for Yumanity Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Total Liabilities Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Total Liabilities

98.56

48.19

34.90

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Liabilities	Get a 7-Day Free Trial							31.75	34.90	18.03	7.13	4.14

Yumanity Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Yumanity Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	20.057	+	(14.843	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	34.90

Total Liabilities	=	Total Assets (A: Dec. 2021 )	-	Total Equity (A: Dec. 2021 )
	=	55.695	-	20.795
	=	34.90

Yumanity Therapeutics's Total Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.144	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4.14

Total Liabilities	=	Total Assets (Q: Sep. 2022 )	-	Total Equity (Q: Sep. 2022 )
	=	9.675	-	5.531
	=	4.14

Yumanity Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines